IFNAR1 and Hepatic fibrosis: To evaluate the role of type I IFN signaling in liver fibrosis, cell proliferation and apoptosis associated with liver regeneration defects, we established an IFNAR1 blockade model by administering IFNAR1 antibodies to CCl4-treated mice for three days prior to liver harvest (Figure 2A) (30).